Abstract
We report a case of pulmonary tuberculosis with transaminitis during the presentation but without any pre-existing liver disease or hepatotoxic drug use. This is a fairly common scenario seen in tuberculosis endemic areas; however, this is an under reported condition in the literature and guidelines for its management has not been established. Many clinicians including the authors have treated such cases with modified liver friendly regimens in fear of increasing the hepatotoxicity with standard drugs. However, the modified regimens may not be optimal in treating the underlying tuberculosis. In this report, we gave full dose standard antitubercular drugs, and the liver injury resolved evidenced by normalization of transaminases.
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference9 articles.
1. https://www.who.int/news-room/fact-sheets/detail/tuberculosis
2. https://nepalntp.gov.np/wp-content/uploads/2020/03/NEPAL-NATIONAL-TB-PREVALENCE-SURVEY-BRIEF-March-24-2020.pdf
3. A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection.;A Hickey;BMC Infect Dis.,2015
4. Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management.;V Ramappa;J Clin Exp Hepatol.,2013
5. Tuberculosis and liver disease: management issues.;U Sonika;Tropical Gastroenterol.,2012